Eli Lilly’s 340B deadline passes: What hospitals should know
(By: Ella Jeffries for Becker’s Hospital Review) Eli Lilly’s deadline for hospitals to submit claims data or lose 340B drug
Read More
340B drug discount program
Health systems sue CVS over alleged $250M 340B scheme
(By: Alan Condon for Becker’s Hospital Review) Three health systems have filed federal lawsuits against CVS Health, alleging the company
Read More
Eli Lilly to expand 340B reporting requirements
(By: Ella Jeffries for Becker’s Hospital Review) Eli Lilly and Co. will require all 340B covered entities to submit claims-level
Read MoreAHA sues to block ‘unlawful’ 340B changes: 4 things to know
(By: Alan Condon for Becker’s Hospital Review) The American Hospital Association, Maine Hospital Association and four safety-net hospitals have filed
Read More5 healthcare policies to watch this month
(By: Madeline Ashley, Erica Cerutti, Alan Condon, and Jakob Emerson for Becker’s Hospital Review) Congress is staring down a fast-approaching
Read MorePressure mounts against HHS’ 340B pilot: 5 notes
(By: Alexandra Murphy for Becker’s Hospital Review) A group of House lawmakers is urging HHS to scrap or revise its
Read MoreThe 340B program, explained
(By: Alexandra Murphy for Becker’s Hospital Review) More than three decades ago, Congress created the 340B program to help safety-net hospitals
Read MoreHow health systems are preparing for a potential 340B overhaul
(By: Alexandra Murphy for Becker’s Hospital Review) As federal scrutiny and legislative proposals continue around the 340B drug pricing program,
Read MoreHRSA warns Sanofi over 340B rebate proposal
(By Alexandra Murphy for Becker’s Hospital Review) The Health Resources and Services Administration has issued a warning to Sanofi over
Read More340B purchases hit $66.3B in 2023
(By Alexandra Murphy for Becker’s Hospital Review) A total of $66.3 billion in outpatient drugs was purchased through the 340B
Read More